Fertility testing is done by both men and women for the assessment of their fertility and various conditions associated with it. A reasonable period of unprotected intercourse without conceiving is a condition referred to as infertility. Couples carry out fertility testing to detect the root causes responsible for their infertility. Men and women both experience the fertility problems at equal rates, but women are considered to be more concerned about fertility testing. The gynecologist or general physician first review the fertility test results to diagnose the exact issue and recommends the corrective measures or treatment accordingly. The rising awareness about fertility testing devices is driving the patient adoption rate effectively for such devices instead of opting for laboratory based tests. Fertility testing is performed at home and is time saving and economical, helps maintain privacy, and is comfortable for females.
Increase in infertility cases due to changing lifestyles in women, growth in awareness about the fertility testing in women, rise in polycystic ovarian syndrome (PCOS) cases, continuous decline in fertility rate in both men and women globally are factors which are expected to drive the growth of the global fertility testing devices market by 2024. The restraints which impact the growth of the global fertility testing devices market are high cost of fertility and ovulating monitors, increase in utilization of mobile applications & websites for ovulation tracking, and easy availability of generic diagnostic tools such as saliva testing and blood testing. Some of the trends in the global fertility testing devices market are monitoring sperm quality by keeping track of heart rate, body temperature, air quality & environmental function, and emergence of technological advances such as trak system. Introduction of various techniques such as hysterosalpingogram, sonohysterogram (ultrasound scan), laparoscopy, and hysteroscopy are projected to boost the growth of the global fertility testing devices market.
The global fertility testing devices market can be segmented by product and end-user. The product segment involves ovulation predictor kits and fertility monitoring devices. The ovulation predictor kits are further segmented into urine based kits, saliva based kits, and others. In 2015, the ovulation predictor kits segment captured a significantly large share in the global fertility testing devices market, which is attributed to lesser cost and user-friendly technique. However, the fertility monitoring devices segment is expected to grow at a higher rate during the forecast period, which is driven by continuous rise in the technological advancements in the fertility monitoring techniques and investments. Based on the end-user segmentation, the global fertility testing devices market is classified into hospitals, specialty clinics, and homecare settings.
Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18689
Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held a significant share of the fertility testing devices market in 2015, which is attributed to the rise in awareness about technological innovations and their benefits in the fertility testing market and increase in prevalence of PCOS. The awareness about the fertility testing is high in the region. Therefore, the use of ovulation predictor kits and fertility monitoring devices is increasing in the North America fertility testing devices market. The anti-mullerian hormone (AMH) test is likely to be adding more value to the existing Europe fertility testing market leading to its further growth in region. Asia Pacific is expected to grow at a higher rate during the forecast period owing to increasing investments in the fertility testing devices market, declining fertility rate, and rising number of women suffering from lifestyle disorder in the region.
Major players operating in the global fertility testing devices market include Hilin Life Products, Church & Dwight Co., Inc., Fairhaven Health LLC, SPD Swiss Precision Diagnostics GmbH, Geratherm Medical AG, AccuQuik, Prestige Brands Holdings, Inc., Quidel Corporation, and Alere Inc.